open access

Vol 48, No 4 (2016)
Review articles
Submitted: 2016-10-28
Get Citation

Neuromuscular blockade in the elderly

Michał Stankiewicz-Rudnicki
DOI: 10.5603/AIT.2016.0045
·
Pubmed: 27797097
·
Anaesthesiol Intensive Ther 2016;48(4):257-260.

open access

Vol 48, No 4 (2016)
Review articles
Submitted: 2016-10-28

Abstract

The aim of the presented review is to highlight the clinical problem of postoperative residual curarization (PORC) following general anaesthesia in the elderly. Possible complications of PORC are described along with age-induced changes in pharmacokinetics of long and intermediate-acting neuromuscular blocking agents. This is intended to facilitate the selection and to promote appropriate intraoperative use of muscle relaxants in patients over the age of 65 years.

Abstract

The aim of the presented review is to highlight the clinical problem of postoperative residual curarization (PORC) following general anaesthesia in the elderly. Possible complications of PORC are described along with age-induced changes in pharmacokinetics of long and intermediate-acting neuromuscular blocking agents. This is intended to facilitate the selection and to promote appropriate intraoperative use of muscle relaxants in patients over the age of 65 years.

Get Citation

Keywords

elderly patients; neuromuscular block, muscle relaxants; neuromuscular block, reversal; postoperative residual curarization

About this article
Title

Neuromuscular blockade in the elderly

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 48, No 4 (2016)

Pages

257-260

DOI

10.5603/AIT.2016.0045

Pubmed

27797097

Bibliographic record

Anaesthesiol Intensive Ther 2016;48(4):257-260.

Keywords

elderly patients
neuromuscular block
muscle relaxants
neuromuscular block
reversal
postoperative residual curarization

Authors

Michał Stankiewicz-Rudnicki

References (44)
  1. Griffiths R, Beech F, Brown A, et al. Association of Anesthetists of Great Britain and Ireland. Peri-operative care of the elderly 2014: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2014; 69 Suppl 1: 81–98.
  2. Urban BW, Bleckwenn M. Concepts and correlations relevant to general anaesthesia. Br J Anaesth. 2002; 89(1): 3–16.
  3. Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology. 2009; 110(5): 1176–1181.
  4. Wickham A, Highton D, Martin D, et al. Pan London Perioperative Audit and Research Network (PLAN). Care of elderly patients: a prospective audit of the prevalence of hypotension and the use of BIS intraoperatively in 25 hospitals in London. Perioper Med (Lond). 2016; 5: 12.
  5. Pietraszewski P, Gaszyński T. Residual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuronium. Anaesthesiol Intensive Ther. 2013; 45(2): 77–81.
  6. Pandit JJ, Andrade J, Bogod DG, et al. The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Anaesthesia. 2014; 69(10): 1089–1101.
  7. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997; 41(9): 1095–1103.
  8. Bell PF, Mirakhur RK, Clarke RS. Dose-response studies of atracurium, vecuronium and pancuronium in the elderly. Anaesthesia. 1989; 44(11): 925–927.
  9. Parker CJ, Hunter JM, Snowdon SL. Effect of age, sex and anaesthetic technique on the pharmacodynamics of atracurium. Br J Anaesth . 1993; 70: 38–41.
  10. Ornstein E, Lien CA, Matteo RS, et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology. 1996; 84(3): 520–525.
  11. Koscielniak-Nielsen ZJ, Bevan JC, Popovic V, et al. Onset of maximum neuromuscular block following succinylcholine or vecuronium in four age groups. Anesthesiology. 1993; 79(2): 229–234.
  12. Naguib M, Samarkandi AH, El-Din ME, et al. The dose of succinylcholine required for excellent endotracheal intubating conditions. Anesth Analg. 2006; 102(1): 151–155.
  13. Han TH, Martyn JAJ. Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus. Br J Anaesth. 2009; 102(1): 55–60.
  14. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg. 1993; 77(6): 1193–1197.
  15. McCarthy G, Elliott P, Mirakhur RK, et al. Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesthesiol Scand. 1992; 36(4): 383–386.
  16. Maddineni VR, Mirakhur RK, McCoy EP, et al. Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Br J Anaesth. 1994; 73(5): 608–612.
  17. Evers BM, Townsend CM, Thompson JC. Organ physiology of aging. Surg Clin North Am. 1994; 74(1): 23–39.
  18. Viby-Mogensen J, Ostergaard D, Donati F, et al. Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). Acta Anaesthesiol Scand. 2000; 44(10): 1169–1190.
  19. Cope TM, Hunter JM. Selecting neuromuscular-blocking drugs for elderly patients. Drugs Aging. 2003; 20(2): 125–140.
  20. Duvaldestin P, Saada J, Berger JL, et al. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology. 1982; 56(1): 36–40.
  21. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg. 1993; 77(6): 1193–1197.
  22. Yamamoto H, Uchida T, Yamamoto Y, et al. Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium. J Anesth. 2011; 25(6): 845–849.
  23. Kocabas S, Yedicocuklu D, Askar FZ. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure. Eur J Anaesthesiol. 2008; 25(11): 940–946.
  24. Furuya T, Suzuki T, Kashiwai A, et al. The effects of age on maintenance of intense neuromuscular block with rocuronium. Acta Anaesthesiol Scand. 2012; 56(2): 236–239.
  25. Slavov V, Khalil M, Merle JC, et al. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anaesth. 1995; 74(6): 709–711.
  26. McCarthy G, Elliott P, Mirakhur RK, et al. Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesthesiol Scand. 1992; 36(4): 383–386.
  27. Lien CA, Matteo RS, Ornstein E, et al. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg. 1991; 73(1): 39–42.
  28. Kisor DF, Schmith VD, Wargin WA, et al. Importance of the organ-independent elimination of cisatracurium. Anesth Analg. 1996; 83(5): 1065–1071.
  29. Fisher DM, Canfell PC, Fahey MR, et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology. 1986; 65(1): 6–12.
  30. Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology. 1990; 72(2): 272–275.
  31. Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology. 1996; 84(5): 1083–1091.
  32. Jin M, Park D, Yang H, et al. Action Duration of Atracurium in the Elderly Patients. Korean Journal of Anesthesiology. 1997; 33(6): 1071–1076.
  33. Arain SR, Kern S, Ficke DJ, et al. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand. 2005; 49(3): 312–315.
  34. Pühringer FK, Heier T, Dodgson M, et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients. Acta Anaesthesiol Scand. 2002; 46(4): 364–371.
  35. Joomye S, Yan D, Wang H, et al. Consumption of Cisatracurium in different age groups, using a closed loop computer controlled system. BMC Anesthesiol. 2014; 14: 29.
  36. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology. 1993; 78(4): 693–699.
  37. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997; 87(5): 1035–1043.
  38. Almeida MC, Camargo DR, Linhares SF, et al. [Evaluation of residual neuromuscular block and late recurarization in the post-anesthetic care unit.]. Rev Bras Anestesiol. 2004; 54(4): 518–531.
  39. Hayes AH, Mirakhur RK, Breslin DS, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001; 56(4): 312–318.
  40. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008; 107(1): 130–137.
  41. Aytac I, Postaci A, Aytac B, et al. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists. Braz J Anesthesiol. 2016; 66(1): 55–62.
  42. Baillard C, Gehan G, Reboul-Marty J, et al. Residual curarization in the recovery room after vecuronium. Br J Anaesth. 2000; 84(3): 394–395.
  43. Murphy GS, Szokol JW, Avram MJ, et al. Residual Neuromuscular Block in the Elderly: Incidence and Clinical Implications. Anesthesiology. 2015; 123(6): 1322–1336.
  44. Cedborg AI, Sundman E, Bodén K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology. 2014; 120(2): 312–325.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl